Biostem

Biostem

Created using Figma
Tecnología de célula bioquímica altamente sofisticada combinada con tecnología blockchain.

Biostem es una tecnología de vanguardia que pretende revolucionar la industria médica y biotecnológica de hoy en día al proporcionar una plataforma descentralizada que se puede usar para actividades transaccionales, seguimiento, fabricación y subcontratación por contrato, monitoreo y registro de datos de pacientes, racionalización de los ciclos de vida de dispositivos médicos y atención médica , fabricación por contrato y gestión de ensayos clínicos. Al hacerlo, también nos aseguramos de que los productos Biotech de hoy en día estén disponibles para todos, no solo los ricos, a precios más baratos.
PRE SALE
1 abr 2019
30 may 2019
100% terminado
Fondos recaudados - sin datos
past
Detalles del token
Distribución de fichas
ICO Crowdfunding 30%
Founder Team 15%
Angel Funding 45%
Publisher 10%
Monedas aceptadas
ETH
Detalles de la compañía
País registrado
Malaysia
Detalles adicionales
Categorías
Plataforma, tecnología

Acerca de Biostem

MYK was established as a biotechnology manufacturer and Biotech Research Laboratory aiming to contribute to the world health and medical industry through globalizing biotechnology. Its main business areas are: health and medical industry, finance and industrial investment, and sophisticated technologies such as blockchain and Biotechnology. MYK regards technology as the core and quality as its life, and wholeheartedly builds the company into a world-class branded enterprise. Comprised of a world-class medical team and cutting-edge biotechnology equipment, MYK provides a global scaled advanced medical technology and research service platform. It provides world-class screening, diagnosis, treatment and rehabilitation services for oncological diseases; has built patient-centered, unique health management system; provide community-based prevention, diagnosis, treatment, rehabilitation, and health services, while also providing medical services. In addition, anti-aging services are supplemented to create a brand-new living experience; in response to the needs of an aging population and the improvement of the quality of life of residents, the company has created the “MYK Cell Bank” as an important carrier for healthy living and provides high-end international medical care. Health management, health care services and other age-based health care services should provide strength for the common people to achieve physical and mental health and a better life.

Biostem is a project by MYK aiming to revolutionize the traditional Medical and Biotechnology industry by providing a decentralized blockchain for storing patient, clinical and research record, and smart contracts like features for trustless outsourcing of Biotech contracts.

Our Mission

Biostem aims to contribute to the world health and medical industry by creating an ecosystem that would make the Patient’s Clinical Record and the Biotech Contract Outsourcing process, distributed through a decentralized blockchain, so that, anyone can have access to high end, state of the art medical diagnosis, treatment and Biotech products at ease.

Biostem

Biostem is state of the art ERC-20 Virtual Currency that allows peer to peer mode of payment and is deployed on decentralized ethereum blockchain based technology. The currency would be used for funding the research work, daily transactional activities happening within the Biostem health and financial ecosystem, for health care services and can also be used as a peer to peer exchange and store of value between users: securely, efficiently at reduced costs. Biostem will utilize ethereum blockchain technology to enhance its services to patients, hospitals, research centers and daily consumers, sellers, and merchants. This allows a level of transparency that was previously unrealized, while incentivizing users to adopt and use the platform. This will be done through the creation and use of Biostems.

Biostem Equipo

Verificado 0%

Atención. Existe el riesgo de que los miembros no verificados no sean realmente miembros del equipo

Dr. Rubern
Chief Executive Officer
inconfirmado
Dawson Roland
Chief Technology Officer
inconfirmado
Kelson Beck
Chief Marketing Officer
inconfirmado
Matthew Hudson
Chief Financial Officer
inconfirmado
Catherine Harrison
Chief Operating Officer
inconfirmado
Rina
Biotech Consultant
inconfirmado
Allyson Brock
Human Resource Director
inconfirmado
Jozie Ayaz Khan
Business Development Director
inconfirmado
Brayden Parker
Biotech Research Consultant
inconfirmado
Sanjay Uttam Kharade
Business Consultant - Asia
inconfirmado

Biostem Últimas noticias

  • Debido a que puede haber diferencias de tiempo en las actualizaciones de información, la información precisa sobre cada proyecto ICO debe verificarse a través de su sitio web oficial u otros canales de comunicación.
  • Esta información no es una sugerencia o consejo para invertir en fondos de la OIC. Por favor, investigue a fondo la información relevante y decida la participación de la OIC.
  • Si cree que hay problemas o correcciones a corregir en este contenido, o si desea enviar su propio proyecto ICO para que aparezca en la lista, por favor envíenos un correo electrónico.
Lea la exención de responsabilidad y la advertencia de riesgo. Mostrar descargo de responsabilidad y advertencia de riesgo.